Controversies in antiplatelet therapy for patients with cardiovascular disease.

Circulation

Volumn 111, Issue 17, 2005, Pages

  Bates, Eric R ^a   Lau, Wei C ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; ATORVASTATIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEPTANOIC ACID DERIVATIVE; PROSTAGLANDIN SYNTHASE INHIBITOR; PYRROLE DERIVATIVE;

ARTICLE; CARDIOVASCULAR DISEASE; DRUG COMBINATION; DRUG INTERACTION; DRUG RESISTANCE; HUMAN;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ASPIRIN; CARDIOVASCULAR DISEASES; CYCLOOXYGENASE INHIBITORS; DRUG INTERACTIONS; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; HEPTANOIC ACIDS; HUMANS; PLATELET AGGREGATION INHIBITORS; PYRROLES;

MLCS; MLOWN;

EID: 19644373481     PISSN: None     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/01.cir.0000157158.63751.b2     Document Type: Article

References (0)